Staley Capital Advisers Has Lowered By $2.07 Million Its Pfizer (PFE) Stake; Shorts at Magna International (MGA) Lowered By 4.33%

Magna International Inc. (NYSE:MGA) Logo

Magna International Inc (NYSE:MGA) had a decrease of 4.33% in short interest. MGA’s SI was 2.12 million shares in March as released by FINRA. Its down 4.33% from 2.21 million shares previously. With 769,600 avg volume, 3 days are for Magna International Inc (NYSE:MGA)’s short sellers to cover MGA’s short positions. The SI to Magna International Inc’s float is 0.64%. The stock increased 0.23% or $0.11 during the last trading session, reaching $48.85. About 1.32 million shares traded or 19.75% up from the average. Magna International Inc. (NYSE:MGA) has declined 1.92% since March 17, 2018 and is downtrending. It has underperformed by 6.29% the S&P500. Some Historical MGA News: 29/03/2018 – Magna Provides Engineering Expertise to New Automaker VinFast; 10/05/2018 – Magna International Had Seen 2018 Net $2.3B-$2.5B; 14/03/2018 – MAGNA INTERNATIONAL INC – IN ADDITION TO FUNDING PARTNERSHIP, MAGNA TO INVEST $200 MLN IN LYFT; 26/04/2018 – Magna and BHAP Create Joint Venture to Supply Door Modules to Automakers in China; 10/05/2018 – MAGNA CEO: NAFTA MUST BE COMPETITIVE OR AUTOMAKERS WILL LEAVE; 10/05/2018 – Magna International Sees 2018 Capital Spending $1.8B; 26/04/2018 – Magna International: Production to Begin in 2021, to Generate Over 100 New Jobs; 19/04/2018 – Magna Opens New Body & Chassis Plant in Mexico; 14/03/2018 – LYFT RAISES $200M FROM MAGNA IN SELF-DRIVING TECH PARTNERSHIP; 29/03/2018 – Magna Establishes Automatic Share Purchase Plan

Staley Capital Advisers Inc decreased Pfizer Inc (PFE) stake by 4.32% reported in 2018Q4 SEC filing. Staley Capital Advisers Inc sold 48,031 shares as Pfizer Inc (PFE)’s stock declined 4.08%. The Staley Capital Advisers Inc holds 1.06 million shares with $46.48M value, down from 1.11M last quarter. Pfizer Inc now has $231.95B valuation. The stock increased 1.43% or $0.59 during the last trading session, reaching $41.78. About 70.94M shares traded or 160.80% up from the average. Pfizer Inc. (NYSE:PFE) has risen 20.88% since March 17, 2018 and is uptrending. It has outperformed by 16.51% the S&P500. Some Historical PFE News: 21/03/2018 – PFIZER – CONTINUES TO EVALUATE POTENTIAL STRATEGIC ALTERNATIVES FOR CONSUMER HEALTHCARE BUSINESS; 10/04/2018 – PFIZER PROVIDES UPDATE ON PHASE 3 TRIAL OF AXITINIB AS ADJUVANT; 01/05/2018 – PFE HASN’T GOTTEN ‘ACCEPTABLE OFFER’ FOR CONSUMER HEALTH UNIT; 17/05/2018 – FDA’S GOTTLIEB – COS FOR WHICH INQUIRIES HAVE BEEN RECEIVED INCLUDE DANCO LABORATORIES, ROXANE LABORATORIES, CORCEPT THERAPEUTICS, AEGERION PHARMA; 18/05/2018 – AstraZeneca hit by falling Crestor sales, higher costs; 23/03/2018 – INNATE PHARMA SA – PARTNER MEDIMMUNE EXPANDS COLORECTAL CANCER PATIENT COHORT IN ONGOING PHASE l TRIAL EVALUATING MONALIZUMAB IN COMBINATION WITH IMFINZI┬« (DURVALUMAB); 11/03/2018 – PFE:ELIQUIS SHOWED LOWER STROKE RATE VS RIVAROXABAN, DABIGATRAN; 19/04/2018 – PFIZER, OTHER LARGE DRUG COS COULD ALSO LOOK AT SHIRE BID: BTIG; 03/04/2018 – Pfizer and Allogene Therapeutics Enter into Asset Contribution Agreement for Pfizer’s Allogeneic CAR T Immuno-oncology; 16/03/2018 – Ian Read, BTW, has been at $PFE for 40 years — and they wanted a noncompete

Investors sentiment decreased to 0.74 in 2018 Q4. Its down 0.11, from 0.85 in 2018Q3. It is negative, as 42 investors sold PFE shares while 792 reduced holdings. 141 funds opened positions while 477 raised stakes. 4.05 billion shares or 2.27% more from 3.96 billion shares in 2018Q3 were reported. State Of New Jersey Common Pension Fund D accumulated 4.25M shares. Moreover, Goelzer Invest Mgmt Inc has 1.07% invested in Pfizer Inc. (NYSE:PFE) for 190,547 shares. Stadion Money Management Lc owns 0.05% invested in Pfizer Inc. (NYSE:PFE) for 27,218 shares. Kingfisher Limited Liability Co owns 38,879 shares or 1.21% of their US portfolio. Stonebridge Advisors Lc holds 0.23% or 22,874 shares in its portfolio. Destination Wealth Mgmt reported 1.29% stake. Steinberg Global Asset has invested 0.95% in Pfizer Inc. (NYSE:PFE). Valmark Advisers holds 0.03% or 31,156 shares. Ruggie Cap Grp holds 0.02% or 997 shares in its portfolio. New York-based Lazard Asset Ltd Limited Liability Company has invested 1% in Pfizer Inc. (NYSE:PFE). Psagot House Limited has invested 0.4% in Pfizer Inc. (NYSE:PFE). Gould Asset Management Ltd Liability Ca owns 28,638 shares or 0.52% of their US portfolio. Lodestar Counsel Lc Il has invested 0.37% in Pfizer Inc. (NYSE:PFE). Confluence Investment Mgmt Ltd holds 1.94% of its portfolio in Pfizer Inc. (NYSE:PFE) for 2.37 million shares. Ronna Sue Cohen owns 0.25% invested in Pfizer Inc. (NYSE:PFE) for 7,790 shares.

More notable recent Pfizer Inc. (NYSE:PFE) news were published by: which released: “Pfizer prices $5B debt offering – Seeking Alpha” on March 05, 2019, also with their article: “The Case Against Pfizer Stock and the Rest of the Industry –” published on March 15, 2019, published: “FDA OKs Pfizer’s Herceptin biosimilar – Seeking Alpha” on March 12, 2019. More interesting news about Pfizer Inc. (NYSE:PFE) were released by: and their article: “Pfizer Inc. (PFE) Management Presents at Cowen and Company 39th Annual Health Care Conference (Transcript) – Seeking Alpha” published on March 12, 2019 as well as‘s news article titled: “Pfizer in-licenses diabetes candidate from AnTolRx – Seeking Alpha” with publication date: March 05, 2019.

Staley Capital Advisers Inc increased Schlumberger (NYSE:SLB) stake by 103,946 shares to 576,090 valued at $20.79 million in 2018Q4. It also upped Ishares Msci Eafe Etf (EFA) stake by 38,251 shares and now owns 44,190 shares. Ishares Russell 1000 Growth (IWF) was raised too.

Since January 30, 2019, it had 0 insider purchases, and 1 sale for $1.81 million activity. $1.81M worth of Pfizer Inc. (NYSE:PFE) was sold by LANKLER DOUGLAS M.

Among 6 analysts covering Pfizer (NYSE:PFE), 3 have Buy rating, 0 Sell and 3 Hold. Therefore 50% are positive. Pfizer had 11 analyst reports since October 31, 2018 according to SRatingsIntel. The stock of Pfizer Inc. (NYSE:PFE) has “Neutral” rating given on Tuesday, December 11 by JP Morgan. On Thursday, November 1 the stock rating was downgraded by BMO Capital Markets to “Market Perform”. Credit Suisse upgraded the shares of PFE in report on Thursday, January 31 to “Outperform” rating. As per Wednesday, October 31, the company rating was maintained by Credit Suisse. On Monday, February 25 the stock rating was initiated by UBS with “Hold”. The firm has “Sell” rating by Citigroup given on Tuesday, November 6. The firm has “Buy” rating given on Tuesday, February 19 by Cantor Fitzgerald. Argus Research upgraded the shares of PFE in report on Thursday, January 31 to “Outperform” rating. UBS downgraded the shares of PFE in report on Wednesday, January 23 to “Neutral” rating.

Analysts await Pfizer Inc. (NYSE:PFE) to report earnings on May, 7. They expect $0.77 earnings per share, 0.00% or $0.00 from last year’s $0.77 per share. PFE’s profit will be $4.27B for 13.56 P/E if the $0.77 EPS becomes a reality. After $0.64 actual earnings per share reported by Pfizer Inc. for the previous quarter, Wall Street now forecasts 20.31% EPS growth.

More notable recent Magna International Inc. (NYSE:MGA) news were published by: which released: “Preview: Magna International (NYSE:MGA) Earnings – Benzinga” on February 21, 2019, also with their article: “Magna International, Inc. (NYSE:MGA) – Magna Posts Record Sales As CEO Bemoans Tariffs – Benzinga” published on February 22, 2019, published: “Magna International Inc. (MGA) CEO Don Walker on Q4 2018 Results – Earnings Call Transcript – Seeking Alpha” on February 22, 2019. More interesting news about Magna International Inc. (NYSE:MGA) were released by: and their article: “10 Stocks To Watch For February 22, 2019 – Benzinga” published on February 22, 2019 as well as‘s news article titled: “Magna Announces Fourth Quarter and 2018 Results and Raises Quarterly Cash Dividend by 11% – GlobeNewswire” with publication date: February 22, 2019.

Among 8 analysts covering Magna International (NYSE:MGA), 5 have Buy rating, 1 Sell and 2 Hold. Therefore 63% are positive. Magna International had 11 analyst reports since October 12, 2018 according to SRatingsIntel. TD Securities upgraded Magna International Inc. (NYSE:MGA) rating on Thursday, January 10. TD Securities has “Buy” rating and $60 target. Wells Fargo maintained it with “Outperform” rating and $63 target in Monday, February 25 report. Citigroup maintained Magna International Inc. (NYSE:MGA) rating on Wednesday, February 27. Citigroup has “Buy” rating and $66 target. Bank of America maintained Magna International Inc. (NYSE:MGA) on Monday, February 25 with “Buy” rating. Morgan Stanley maintained the stock with “Sell” rating in Tuesday, February 26 report. The firm earned “Hold” rating on Sunday, February 24 by Barclays Capital. The firm has “Buy” rating by BMO Capital Markets given on Friday, February 22. The firm has “Buy” rating given on Friday, October 12 by Citigroup.

Magna International Inc. designs, develops, and makes automotive systems, assemblies, modules, and components in North America, Europe, Asia, and South America. The company has market cap of $15.83 billion. The firm offers engineering and contract manufacturing services, and fuel systems; electric/electronic components and systems; roof systems comprising softtops, retractable hardtops, modular tops, and hardtops; and closures, including latching systems, hinges and wire forming, power closures, electronics, door modules, window systems engineered glass, sealing, trim and roof racks, roof systems, testing centers, and running boards. It has a 7.39 P/E ratio. It also provides interior and exterior mirrors, actuators, electronic vision systems, door handle and overhead console technologies, and front and signal lightings; complete seating systems, mechanism solutions, seat structure solutions, foam and trim products, and design and development solutions; and fascia and exterior trims, liftgate and exterior modules, front end modules, ACTERO active aerodynamics, and lightweight composites.

Pfizer Inc. (NYSE:PFE) Institutional Positions Chart